Role of C-peptide in human physiology

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 5 41-5, 2000, Pages

  Wahren, John ^a   Ekberg, Karin ^a   Johansson, Jan ^b   Henriksson, Mikael ^b   Pramanik, Aladdin ^b   Johansson, Bo Lennart ^a   Rigler, Rudolf ^b   Jörnvall, Hans ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autonomic nerve function; Endothelial nitric oxide synthase; G protein; Renal function; Sodium potassium adenosine 5' triphosphatase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; G PROTEIN COUPLED RECEPTOR; INSULIN; NEUROPEPTIDE Y; PROINSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C;

AMINO ACID SEQUENCE; CALCIUM TRANSPORT; FLUORESCENCE; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034041925     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.5.e759     Document Type: Review

References (68)

1. +-ATPase: a final common pathway for regulation of natriuresis. FASEB J 8: 436-439, 1994.
2. Bessalle R, Kapitkovsky A, Gorea A, Shalit I, and Fridkin M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274: 151-155, 1990.
3. Cameron N, Cotter M, Basso M, and Hohman T. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40: 271-281, 1997.
4. Djemli A, Gallice P, Coste T, Jannot M, Dufayet D, Raccah D, and Vague P. Ex vivo and in vitro effects of insulin and C-peptide on Na/K ATPase activity in red blood cell membranes of type 1 diabetic patients (Abstract). Diabetologia 42, Suppl 1: A154, 1999.
5. Doucet A, Katz AI, and Morel F. Determination of Na-K-ATPase activity in single segments of the mammalian nephron. Am J Physiol Renal Fluid Electrolyte Physiol 237: F105-F113, 1979.
6. Dryburgh J, Hampton S, and Marks V. Endocrine pancreatic control of the release of gastic inhibitory polypeptide. Diabetologia 19: 397-401, 1980.
7. Dufayet de la Tour, D, Raccah D, Jannot M, Coste T, Rougerie C, and Vague P. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41: 1080-1084, 1998.
8. Dunbar J, McLaughlin W, Walsh M-F, and Foà P. Insulin secretion and glucose uptake by isolated islets of the hamster. Effects of insulin, proinsulin and C-peptide. Horm Metab Res 8: 1-6, 1976.
9. Eigen M and Rigler R. Sorting single molecules: application to diagnostics and evolutionary biotechnology. Proc Natl Acad Sci USA 91: 5740-5747, 1994.
10. Flatt PR, Swanston-Flatt SK, Hampton SM, Bailey CJ, and Marks V. Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep 6: 193-199, 1986.
11. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, and Pfützner A. Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus. J Clin Invest 101: 2036-2041, 1998.
12. Friedman E, Sheih S-D, Hirsch S, and Boshell B. No supranormal glomerular filtration (GFR) in type II (non-insulin-dependent) diabetes (Abstract). Am Soc Nephrol 14: 102A, 1981.
13. Gregory R and Tracy H. The constitution and properties of two gastrins extracted from hog antral mucose. Gut 5: 103-117, 1964.
14. Hagen C, Faber O, Binder C, and Alberti K. Lack of metabolic effect of C-peptide in normal subjects and juvenile diabetic patients (Abstract). Acta Endocrinologica 85: 29, 1977.
15. Hamm HE. The many faces of G protein signaling. J Biol Chem 273: 669-672, 1998.
16. Henriksson M, Shafqat J, Liepinsh E, Tally M, Wahren J, Jörnvall H, and Johansson J. Unordered structure of proinsulin C-peptide in aqueous solution and in the presence of lipid vesicles. Cell Mol Life Sci 57: 337-342, 2000.
17. Hoogwerf B, Bantle J, Gaenslen H, Greenberg B, Senske B, Francis R, and Goetz F. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122-125, 1986.
18. +-ATPase activity by dopamine and α-adrenergic agonist. Proc Natl Acad Sci USA 90: 21-24, 1993.
19. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath W, DiMarchi R, Cera ED, and Williamson J. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 211: 563-566, 1997.
20. Jack A, Cameron N, and Cotter M. Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats. J Diabetes Complications 13: 2-9, 1999.
21. Jansson L. Effects of C-peptide on splanchnic blood flow in anaesthetised rats. Med Sci res 23: 157-158, 1995.
22. Jehle PM, Fussgänger RD, Angelus NKD, Jungwirth RJ, Saile B, and Lutz MP. Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors. Am J Physiol Endocrinol Metab 276: E262-E268, 1999.
23. Jehle P, Lutz M, and Fussgänger R. High affinity binding sites for proinsulin in human IM-9 lymphoblasts. Diabetologia 39: 421-432, 1996.
24. Jensen ME and Messina EJ. C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol Heart Circ Physiol 276: H1223-H1228, 1999.
25. Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, and Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes - a three-month study. Diabetic Med 17: 181-189, 2000.
26. Johansson B-L, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, and Wahren J. C-peptide improves autonomic nerve function in patients with type 1 diabetes. Diabetologia 39: 687-695, 1996.
27. Johansson B-L, Kernell A, Sjöberg S, and Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976-981, 1993.
28. Johansson B-L, Linde B, and Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type I (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158, 1992.
29. Johansson B-L, and Pernow J. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin dependent diabetic patients. Acta Physiol Scand 165: 39-44, 1999.
30. Johansson B-L, Pernow J, and Wahren J. Muscle vasodilatation by C-peptide is NO-mediated (Abstract). Diabetologia 42 Suppl 1: A324, 1999.
31. Johansson B-L, Sjöberg S, and Wahren J. The influence of human C-peptide on renal function and glucose utilization in type I (insulin-dependent) diabetic patients. Diabetologia 35: 121-128, 1992.
32. Kaneto T, Kaneto A, Yanihara N, Yasuda H, Suzuki S, Oka H, and Oda T. Proinsulin, Insulin and C-Peptide, edited by S Baba, T Kaneto, and N Yanihara. Amsterdam: Excerpta Medica, 1979, p. 138-147.
33. Kitabchi A. Proinsulin and C-peptide. Metabolism 26: 547-587, 1977.
34. Kunt T, Forst T, Closs E, Wallerath U, Förstermann R, Lehmann R, Pfützner A, Harzer O, Engelback M, and Beyer J. Activation of endothelial nitric oxide synthase (eNOS) by C-peptide (Abstract). Diabetologia 41: A176, 1998.
35. Kunt T, Schneider S, Pfützner A, Goitum K, Engelbach M, Schauf B, Beyer J, and Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus. Diabetologia 42: 465-471, 1999.
36. Lindström K, Johansson C, Johnsson E, and Haraldsson B. Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscle and kidneys in rat. Acta Physiol Scand 156: 19-25, 1996.
37. Ling L, Oshida Y, Kusunoki M, Yamanouchi K, Johansson B, Wahren J, and Sato Y. Rat C-peptide I and II stimulates utilization in STZ-induced diabetic rats. Diabetologia 42: 958-964, 1999.
38. Maiti S, Haupts U, and Webb W. Fluorescence correlation spectroscopy: diagnostics for sparse molecules. Proc Natl Acad Sci USA 94: 11753-11757, 1997.
39. Mogensen C and Andersen M. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 707-712, 1973.
40. Mogensen C and Andersen M. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Normalisation by insulin treatment. Diabetologia 11: 221-224, 1975.
41. Mutt V and Jorpes J. Structure of porcine cholecystokinin-pancreozymin. Eur J Biochem 6: 156-162, 1968.
42. +ATPase activity in synergism with neuropeptide Y. Diabetologia 39: 199-205, 1996.
43. +-ATPase activity of renal tubule segments. Diabetologia 41: 287-291, 1998.
44. Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson O, Nygren P-Å, Ståhl S, Ekberg K, Johansson B-L, Uhlén S, Uhlén M, Jörnvall H, and Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96: 1318-1323, 1999.
45. Rubenstein A, Clark J, Melani F, and Steiner D. Secretion of proinsulin, C-peptide by pancreatic beta cells and its circulation in blood. Nature 224: 697-699, 1969.
46. Sandahl-Christiansen J, Frandsen M, and Parving H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20: 199-204, 1981.
47. Schlesinger P, Ido Y, and Williamsson J. Conductive channel properties of human C-peptide incorporated into planar lipid bilayers (Abstract). Diabetes 47: A29, 1998.
48. Schmitz A, Gundersen H, and Österby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 37: 38-43, 1988.
49. Sjöberg S, Johansson B-L, Östman J, and Wahren J. Renal and splanchnic exchange of human biosynthetic C-peptide in type I (insulin-dependent) diabetes mellitus. Diabetologia 34: 423-428, 1991.
50. Sjöquist M, Huang W, and Johansson B-L. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54: 758-764, 1998.
51. Steiner D, Bell G, and Tager H. Chemistry and biosynthesis of pancreatic protein hormones. In: Endocrinology, edited by L DeGroot. Philadelphia, PA: Saunders, 1995, p. 1296-1328.
52. Steiner D, Cunningham D, Spigelman L, and Aten B. Insulin biosynthesis: evidence for a precursor. Science 157: 697-700, 1967.
53. Steiner D and Oyer P. Biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57: 473-481, 1967.
54. Sugimoto K, Zhang W-X, Xu G, Wahren J, and Sima A. Expression of insulin and IGF-I receptors' mRNAs in peripheral nerve of type 1 diabetic BB/W-rat: effects of C-peptide (Abstract). Diabetologia 42 Suppl 1: A291, 1999.
55. Tager H and Steiner D. Primary structures of the proinsulin connecting peptides of the rat and the horse. J Biol Chem 247: 7936-7940, 1972.
56. Thomas P. Diabetic neuropathy: epidemiology and pathogenesis. In: Textbook of Diabetes, edited by J Pickup and G Williams. Oxford: Blackwell, 1991, p. 613-622.
57. Toyota T, Abe K, and Kudo A. Inhibitory action of rat insulin and synthetic rat C-peptide on insulin secretion in the perfused rat pancreas. Acta Diabetol Lat 14: 250-256, 1977.
58. Toyota T, Abe K, Kudo M, Kimura K, and Goto Y. Inhibitory effects of synthetic rat C-peptide 1 on insulin secretion in the isolated perfused rat pancreas. Tohoku J Exp Med 117: 79-83, 1975.
59. Wahlestedt C, Håkansson R, Vaz C, and Zukowska-Grojec Z. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am J Physiol Regulatory Integrative Comp Physiol 258: R736-R742, 1990.
60. +ATPase activity (Abstract). Eur J Endocrinol 136, Suppl 1: 16, 1997.
61. +ATPase activity: a negative feedback mechanism on insulin secretion? (Abstract) Diabetologia 39, Suppl 1: A71, 1996.
62. White J, Olchovsky D, Kershaw M, and Berelowit M. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126: 765-772, 1990.
63. Wójcikowski C, Fussgänger R, and Pfeiffer E. Inhibition of insulin and glucagon secretion of the isolated rat pancreas by synthetic human and rat C-peptide. In: C-Peptide, edited by J Beyer, U Krause, and W Naegele. Konstanz: Schnetzor-Verlag, 1977, p. 75-88.
64. Wójcikowski C, Maier V, Dominiak K, Fussgänger R, and Pfeiffer E. Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288-290, 1983.
65. Wu W, Oshida Y, Yang W-P, Ohsawa I, Sato J, Iwao S, Johansson B-L, Wahren J, and Sato Y. Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats. Acta Physiol Scand 157: 253-258, 1996.
66. Zierath J. In vitro studies of human skeletal muscle: hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 155, Suppl 626: 66, 1995.
67. Zierath J, Galuska D, Johansson B-L, and Wallberg-Henriksson H. Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia 34: 899-901, 1991.
68. Zierath J, Handberg A, Tally M, and Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39: 306-313, 1996.